Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.

Grayburn PA, Weiss JL, Hack TC, Klodas E, Raichlen JS, Vannan MA, Klein AL, Kitzman DW, Chrysant SG, Cohen JL, Abrahamson D, Foster E, Perez JE, Aurigemma GP, Panza JA, Picard MH, Byrd BF, Segar DS, Jacobson SA, Sahn DJ, DeMaria AN.

Open source

DOI: 10.1016/s0735-1097(98)00219-8
Published: 1998-07-01
Container: J Am Coll Cardiol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0735-1097-98-00219-8,
  title = {Phase III multicenter trial comparing the efficacy of 2\% dodecafluoropentane emulsion (EchoGen) and sonicated 5\% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.},
  author = {Grayburn PA and  Weiss JL and  Hack TC and  Klodas E and  Raichlen JS and  Vannan MA and  Klein AL and  Kitzman DW and  Chrysant SG and  Cohen JL and  Abrahamson D and  Foster E and  Perez JE and  Aurigemma GP and  Panza JA and  Picard MH and  Byrd BF and  Segar DS and  Jacobson SA and  Sahn DJ and  DeMaria AN.},
  year = {1998},
  journal = {J Am Coll Cardiol},
  doi = {10.1016/s0735-1097(98)00219-8},
  url = {https://doi.org/10.1016/s0735-1097(98)00219-8}
}

RIS

TY  - JOUR
TI  - Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
AU  - Grayburn PA
AU  -  Weiss JL
AU  -  Hack TC
AU  -  Klodas E
AU  -  Raichlen JS
AU  -  Vannan MA
AU  -  Klein AL
AU  -  Kitzman DW
AU  -  Chrysant SG
AU  -  Cohen JL
AU  -  Abrahamson D
AU  -  Foster E
AU  -  Perez JE
AU  -  Aurigemma GP
AU  -  Panza JA
AU  -  Picard MH
AU  -  Byrd BF
AU  -  Segar DS
AU  -  Jacobson SA
AU  -  Sahn DJ
AU  -  DeMaria AN.
PY  - 1998
JO  - J Am Coll Cardiol
DO  - 10.1016/s0735-1097(98)00219-8
UR  - https://doi.org/10.1016/s0735-1097(98)00219-8
ER  -

APA

PA, G., JL, W., TC, H., E, K., JS, R., MA, V., AL, K., DW, K., SG, C., JL, C., D, A., E, F., JE, P., GP, A., JA, P., MH, P., BF, B., DS, S., SA, J., DJ, S., & AN., D. (1998). Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.. J Am Coll Cardiol. https://doi.org/10.1016/s0735-1097(98)00219-8

Source records

europe-pmc · retrieved 2026-09-27T08:17:03.120Z